Randomised trial of neo-adjuvant therapy in patients with stage IIIA non small cell lung cancer

Phase 3

Completed

• Conditions: Cancer; Non small cell lung (NSCL) cancer

• Registration Number: ISRCTN54157750
• Lead Sponsor: Medical Research Council (MRC) (UK)

Brief Summary

2005 results in https://www.ncbi.nlm.nih.gov/pubmed/15908042 (added 20/02/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 1999-05-01
• Study Start: 2001-02-28
• Last Update Posted: 3 March 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

1. No previous treatment for the current lung cancer
2. Either sex
3. World Health Organisation (WHO) 0-2, T3N1M0 or T1-3N2M0 stage

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified